The site is undergoing maintenance on
Thursday, September 10, 9:00 pm through Friday, September 11, 9:00 pm (BRT), 2026.
If you encounter problems while ordering, please contact us at BDBCustomerService@bd.com
See More
The site is undergoing maintenance on
Thursday, September 10, 9:00 pm through Friday, September 11, 9:00 pm (BRT), 2026.
If you encounter problems while ordering, please contact us at BDBCustomerService@bd.com
See MoreThe site is undergoing maintenance on
Thursday, September 10, 9:00 pm through Friday, September 11, 9:00 pm (BRT), 2026
.If you encounter problems while ordering, please contact us at BDBCustomerService@bd.com
Looks like you're visiting us from {countryName}.
Would you like to stay on the current country site or be switched to your country?
Multicolor flow cytometric analysis of CD369 (CLEC7A) expression on viable Mouse peritoneal exudate cells (PEC). BALB/c Mouse thioglycolate-elicited PEC cells were harvested and pre-incubated with Purified Rat Anti-Mouse CD16/CD32 antibody (Mouse BD Fc Block™) [Cat. No. 553141/553142]. The cells were then stained with Alexa Fluor™ 647 Rat Anti-Mouse F4/80 antibody (Cat. No. 565853) and with either BD Horizon™ BV421 Mouse IgG1, κ Isotype Control (Left Plot) or BD Horizon™ BV421 Mouse Anti-Mouse CD369 (CLEC7A) antibody (Right Plot) at 0.5 ug/test. BD Via-Probe™ Cell Viability 7-AAD Solution was added to cells right before analysis. The bivariate pseudocolor density plot showing the correlated expression of CD369 (CLEC7A) [or Ig Isotype control staining] versus F4/80 was derived from 7-AAD-negative gated events with the forward and side light-scatter characteristics of viable PEC cells. Flow cytometry and data analysis were performed using a BD LSRFortessa™ X-20 Cell Analyzer System and FlowJo™ software. Data shown on this Technical Data Sheet are not lot specific.
Multicolor flow cytometric analysis of CD369 (CLEC7A) expression on viable Mouse peripheral blood leukocytes (PBL). BALB/c Mouse peripheral blood leukocytes (PBL) were stained with APC Rat Anti-Mouse Ly-6G antibody (Cat. No. 560599) and with either BD Horizon™ BV421 Mouse IgG1, κ Isotype Control (Cat. No. 562438) or BD Horizon™ BV421 Mouse Anti-Mouse CD369 (CLEC7A) antibody (Cat. No. 569709/569710; Right Plot) at 0.5 ug/test. BD Via-Probe™ Cell Viability 7-AAD Solution (Cat. No. 555815/555816) was added to cells right before analysis. The bivariate pseudocolor density plot showing the correlated expression of CD369 (CLEC7A) [or Ig Isotype control staining] versus Ly-6G was derived from 7-AAD-negative gated events with the forward and side light-scatter characteristics of viable leukocyte populations. Flow cytometry and data analysis were performed using a BD LSRFortessa™ X-20 Cell Analyzer System and FlowJo™ software. Data shown on this Technical Data Sheet are not lot specific.
Multicolor flow cytometric analysis of CD369 (CLEC7A) expression on viable Mouse peritoneal exudate cells (PEC). BALB/c Mouse thioglycolate-elicited PEC cells were harvested and pre-incubated with Purified Rat Anti-Mouse CD16/CD32 antibody (Mouse BD Fc Block™) [Cat. No. 553141/553142]. The cells were then stained with Alexa Fluor™ 647 Rat Anti-Mouse F4/80 antibody (Cat. No. 565853) and with either BD Horizon™ BV421 Mouse IgG1, κ Isotype Control (Left Plot) or BD Horizon™ BV421 Mouse Anti-Mouse CD369 (CLEC7A) antibody (Right Plot) at 0.5 ug/test. BD Via-Probe™ Cell Viability 7-AAD Solution was added to cells right before analysis. The bivariate pseudocolor density plot showing the correlated expression of CD369 (CLEC7A) [or Ig Isotype control staining] versus F4/80 was derived from 7-AAD-negative gated events with the forward and side light-scatter characteristics of viable PEC cells. Flow cytometry and data analysis were performed using a BD LSRFortessa™ X-20 Cell Analyzer System and FlowJo™ software. Data shown on this Technical Data Sheet are not lot specific.
Multicolor flow cytometric analysis of CD369 (CLEC7A) expression on viable Mouse peripheral blood leukocytes (PBL). BALB/c Mouse peripheral blood leukocytes (PBL) were stained with APC Rat Anti-Mouse Ly-6G antibody (Cat. No. 560599) and with either BD Horizon™ BV421 Mouse IgG1, κ Isotype Control (Cat. No. 562438) or BD Horizon™ BV421 Mouse Anti-Mouse CD369 (CLEC7A) antibody (Cat. No. 569709/569710; Right Plot) at 0.5 ug/test. BD Via-Probe™ Cell Viability 7-AAD Solution (Cat. No. 555815/555816) was added to cells right before analysis. The bivariate pseudocolor density plot showing the correlated expression of CD369 (CLEC7A) [or Ig Isotype control staining] versus Ly-6G was derived from 7-AAD-negative gated events with the forward and side light-scatter characteristics of viable leukocyte populations. Flow cytometry and data analysis were performed using a BD LSRFortessa™ X-20 Cell Analyzer System and FlowJo™ software. Data shown on this Technical Data Sheet are not lot specific.
Multicolor flow cytometric analysis of CD369 (CLEC7A) expression on viable Mouse peritoneal exudate cells (PEC). BALB/c Mouse thioglycolate-elicited PEC cells were harvested and pre-incubated with Purified Rat Anti-Mouse CD16/CD32 antibody (Mouse BD Fc Block™) [Cat. No. 553141/553142]. The cells were then stained with Alexa Fluor™ 647 Rat Anti-Mouse F4/80 antibody (Cat. No. 565853) and with either BD Horizon™ BV421 Mouse IgG1, κ Isotype Control (Left Plot) or BD Horizon™ BV421 Mouse Anti-Mouse CD369 (CLEC7A) antibody (Right Plot) at 0.5 ug/test. BD Via-Probe™ Cell Viability 7-AAD Solution was added to cells right before analysis. The bivariate pseudocolor density plot showing the correlated expression of CD369 (CLEC7A) [or Ig Isotype control staining] versus F4/80 was derived from 7-AAD-negative gated events with the forward and side light-scatter characteristics of viable PEC cells. Flow cytometry and data analysis were performed using a BD LSRFortessa™ X-20 Cell Analyzer System and FlowJo™ software. Data shown on this Technical Data Sheet are not lot specific.
Multicolor flow cytometric analysis of CD369 (CLEC7A) expression on viable Mouse peripheral blood leukocytes (PBL). BALB/c Mouse peripheral blood leukocytes (PBL) were stained with APC Rat Anti-Mouse Ly-6G antibody (Cat. No. 560599) and with either BD Horizon™ BV421 Mouse IgG1, κ Isotype Control (Cat. No. 562438) or BD Horizon™ BV421 Mouse Anti-Mouse CD369 (CLEC7A) antibody (Cat. No. 569709/569710; Right Plot) at 0.5 ug/test. BD Via-Probe™ Cell Viability 7-AAD Solution (Cat. No. 555815/555816) was added to cells right before analysis. The bivariate pseudocolor density plot showing the correlated expression of CD369 (CLEC7A) [or Ig Isotype control staining] versus Ly-6G was derived from 7-AAD-negative gated events with the forward and side light-scatter characteristics of viable leukocyte populations. Flow cytometry and data analysis were performed using a BD LSRFortessa™ X-20 Cell Analyzer System and FlowJo™ software. Data shown on this Technical Data Sheet are not lot specific.
Any use of products other than the permitted use without the express written authorization of Becton, Dickinson and Company is strictly prohibited.
BD® CompBeads can be used as surrogates to assess fluorescence spillover (compensation). When fluorochrome conjugated antibodies are bound to BD® CompBeads, they have spectral properties very similar to cells. However, for some fluorochromes there can be small differences in spectral emissions compared to cells, resulting in spillover values that differ when compared to biological controls. It is strongly recommended that when using a reagent for the first time, users compare the spillover on cells and BD® CompBeads to ensure that BD® CompBeads are appropriate for your specific cellular application.
For optimal and reproducible results, BD Horizon Brilliant Stain Buffer should be used anytime BD Horizon Brilliant dyes are used in a multicolor flow cytometry panel. Fluorescent dye interactions may cause staining artifacts which may affect data interpretation. The BD Horizon Brilliant Stain Buffer was designed to minimize these interactions. When BD Horizon Brilliant Stain Buffer is used in the multicolor panel, it should also be used in the corresponding compensation controls for all dyes to achieve the most accurate compensation. For the most accurate compensation, compensation controls created with either cells or beads should be exposed to BD Horizon Brilliant Stain Buffer for the same length of time as the corresponding multicolor panel. More information can be found in the Technical Data Sheet of the BD Horizon Brilliant Stain Buffer (Cat. No. 563794/566349) or the BD Horizon Brilliant Stain Buffer Plus (Cat. No. 566385).
The 2F3 monoclonal antibody specifically recognizes CD369 which is also known as Dectin-1 (Dendritic cell-associated C-type lectin 1) or BGR (Beta-glucan receptor). CD369 is a ~ 43 kDa type II transmembrane C-type lectin that is encoded by Clec7a (C-type lectin domain family 7, member a). The extracellular portion of CD369 (Clec7a) contains a C-terminal stalk with a carbohydrate recognition domain (CRD) that is followed by a transmembrane segment, and an ITAM-containing cytoplasmic tail. This protein is predominantly expressed on monocytes/macrophages, neutrophils and some dendritic cell populations and at a lower level on a sub-population of T cells. CD369 (Clec7a) binds to beta-glucan polymers and functions as a pattern recognition receptor (PRR) in innate immune response to fungal and bacterial pathogens. CD369 mediated signaling may play a role in leucocyte responses, including phagocytosis or enhanced cytokine production. In mice, two functionally different full-length and stalkless isoforms have been characterized. Both isoforms vary in their ability to recognize zymosan and mediate cellular responses upon zymosan recognition.
Please refer to Support Documents for Quality Certificates
Global - Refer to manufacturer's instructions for use and related User Manuals and Technical data sheets before using this products as described
Comparisons, where applicable, are made against older BD Technology, manual methods or are general performance claims. Comparisons are not made against non-BD technologies, unless otherwise noted.
For Research Use Only. Not for use in diagnostic or therapeutic procedures.